APA (7th ed.) Citation

Johnson, M. P., Muhlhauser, M. A., Nisenbaum, E. S., Simmons, R. M. A., Forster, B. M., Knopp, K. L., . . . Monn, J. A. (2017). Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models. British Journal of Pharmacology, 174(9), 822. https://doi.org/10.1111/bph.13740

Chicago Style (17th ed.) Citation

Johnson, Michael P., et al. "Broad Spectrum Efficacy with LY2969822, an Oral Prodrug of Metabotropic Glutamate 2/3 Receptor Agonist LY2934747, in Rodent Pain Models." British Journal of Pharmacology 174, no. 9 (2017): 822. https://doi.org/10.1111/bph.13740.

MLA (9th ed.) Citation

Johnson, Michael P., et al. "Broad Spectrum Efficacy with LY2969822, an Oral Prodrug of Metabotropic Glutamate 2/3 Receptor Agonist LY2934747, in Rodent Pain Models." British Journal of Pharmacology, vol. 174, no. 9, 2017, p. 822, https://doi.org/10.1111/bph.13740.